Leerink Partners首次覆盖Satellos Bioscience,给予"跑赢大盘"评级,目标价20美元

美股速递
Apr 06

投资银行Leerink Partners近日发布研究报告,首次将生物科技公司Satellos Bioscience Inc.(股票代码:MSLE)纳入覆盖范围。

该机构给予该公司"跑赢大盘"的积极评级,并设定了20美元的目标股价。这一评级反映了分析师对Satellos Bioscience未来发展前景的乐观预期。

作为一家专注于创新疗法研发的生物技术企业,Satellos Bioscience凭借其独特的技术平台吸引了市场关注。Leerink Partners此次覆盖,将为投资者提供专业的研究参考。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10